Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Oakland’s move to change its airport name to include the San Francisco Bay has irritated its bigger-city neighbors.
The US’ often neglected railways might be on track for better days as the country pumps billions of dollars into outdated infrastructure.
The company’s flagship Modelo brand continues as top dog after surpassing Bud Light in sales last year.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The gaming industry, like every other sector including banking and rideshare apps, is enmeshing itself even deeper into advertising.
The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.
The filings signal the growing use cases for AI in healthcare settings, but also the risks that may accompany using AI in clinical care.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Ford wants to charge EVs when renewables are ripe, according to its latest patent.
A GLP-1 medication from French drugmaker Sanofi — similar to Ozempic — was found to slow Parkinson’s in a small mid-stage trial.
Alaska Airlines has received $160 million from Boeing in compensation after a door plug blew off one of its planes.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.